Skip to main content
TipRanks
Go Ultimate75% OFF

National Health Investors (WX6) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

National Health Investors has a market cap or net worth of EUR 2.80B. The enterprise value is EUR 3.89B.

Market Cap
EUR 2.80B
Enterprise Value
EUR 3.89B

Share Statistics

National Health Investors has 49,110,435 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
49,110,435
Owned by Insiders
2.39%
Owned by Institutions
79.84%

Financial Efficiency

National Health Investors’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is 6.97%.

Return on Equity (ROE)
0.09
Return on Assets (ROA)
0.05
Return on Invested Capital (ROIC)
6.97%
Return on Capital Employed (ROCE)
0.07
Revenue Per Employee
11.83M
Profits Per Employee
4.44M
Employee Count
32
Asset Turnover
0.14
Inventory Turnover
0.00

Valuation Ratios

The current PE Ratio of National Health Investors is 4.42. National Health Investors’s PEG ratio is 0.01.

PE Ratio
4.42
PS Ratio
6.76
PB Ratio
1.48
Price to FCF
14.86
Price to Operating Cash Flow
13.07
PEG Ratio
0.01

Income Statement

In the last 12 months, National Health Investors had revenue of 378.53M and earned 142.18M in profits. Earnings per share was 3.03.

Revenue
378.53M
Gross Profit
138.93M
Operating Income
194.83M
Pretax Income
140.79M
Net Income
142.18M
EBITDA
282.00M
Earnings Per Share (EPS)
3.03

Cash Flow

In the last 12 months, operating cash flow was 236.24M and capital expenditures -28.15M, giving a free cash flow of 208.09M billion.

Operating Cash Flow
236.24M
Free Cash Flow
208.09M
Free Cash Flow per Share
4.24

Dividends & Yields

National Health Investors pays an annual dividend of ―, resulting in a dividend yield of 5.79%

Dividend Per Share
―
Dividend Yield
5.79%
Payout Ratio
N/A
Free Cash Flow Yield
6.73%
Earnings Yield
22.59%

Stock Price Statistics

Beta
0.05
52-Week Price Change
-15.27%
50-Day Moving Average
57.90
200-Day Moving Average
63.48
Relative Strength Index (RSI)
43.45
Average Volume (3m)
235

Important Dates

National Health Investors upcoming earnings date is Feb 23, 2027, TBA (Not Confirmed).

Last Earnings Date
Nov 09, 2026
Next Earnings Date
Feb 23, 2027
Ex-Dividend Date
―

Financial Position

National Health Investors as a current ratio of 2.48, with Debt / Equity ratio of 76.49%

Current Ratio
2.48
Quick Ratio
2.48
Debt to Market Cap
0.33
Net Debt to EBITDA
4.06
Interest Coverage Ratio
3.40

Taxes

In the past 12 months, National Health Investors has paid 0 in taxes.

Income Tax
0
Effective Tax Rate
0.00

Enterprise Valuation

National Health Investors EV to EBITDA ratio is 4.80, with an EV/FCF ratio of 19.65.

EV to Sales
8.94
EV to EBITDA
4.80
EV to Free Cash Flow
19.65
EV to Operating Cash Flow
17.31

Balance Sheet

National Health Investors has EUR 46.56M in cash and marketable securities with EUR 1.04B in debt, giving a net cash position of -EUR 997.50M billion.

Cash & Marketable Securities
EUR 46.56M
Total Debt
EUR 1.04B
Net Cash
-EUR 997.50M
Net Cash Per Share
-EUR 20.31
Tangible Book Value Per Share
EUR 42.97

Margins

Gross margin is 50.57%, with operating margin of 39.86%, and net profit margin of 152.55%.

Gross Margin
50.57%
Operating Margin
39.86%
Pretax Margin
152.33%
Net Profit Margin
152.55%
EBITDA Margin
186.19%
EBIT Margin
164.74%

Analyst Forecast

The average price target for National Health Investors is EUR 67.32, which is 11.43% higher than the current price. The consensus rating is Moderate Buy

Price Target
EUR 67.32
Price Target Upside
21.29% Upside
Analyst Consensus
Moderate Buy
Analyst Count
5
Revenue Growth Forecast
21.66%
EPS Growth Forecast
326.52%

Scores

Smart Score
6
AI Score
―